The Middle East & Africa pipette market is expected to reach US$ 69.85 million by 2027 from US$ 58.47million in 2019. The market is estimated to grow with a CAGR of 2.4% from 2020–2027.
The growth of the market is attributed to some key driving factors such as development in pharmaceutical industry and an upsurge in development of biotechnology industry. However, the high cost of electronic pipettes is expected to obstruct the growth of the market to a certain extent during the forecast period.
The rise in number of pharmaceutical industry will also increase drug development and research and development activities in the coming years which will boost the pipette market in the Middle East & Africa region. For instance, Saudi Arabia and São Paulo are looking forward to be the pharmaceutical hub for the Middle East and North African region. The decision was taken at a seminar held at Arab Brazilian Chamber of Commerce in October 2019, in São Paulo. Further, lifestyle changes have led to higher incidences of non-contagious chronic diseases and conditions mostly being cardiovascular disease, obesity and type-2 diabetes. The growing Aging population is promising for foreign businesses looking to enter the market, as there are new challenges and demands to fulfil that the domestic companies cannot fulfill. Besides, it is expected that the pharmaceutical market in Saudi Arabia is expected to grow at a phenomenal rate. The growth is due to factors such as tremendously rising population, increasing incidences of the chronic diseases, rising infrastructure for the healthcare facilities centers, diagnostic laboratories, and clinical research laboratories, among others.
Based on type, the pipette market is segmented into air displacement pipette, and positive displacement pipette. The air displacement pipette segment held a larger share of the market in 2019, whereas the positive displacement pipette segment is anticipated to register a higher CAGR in the market during the forecast period.
Based on category, the pipette market is segmented into manual and electronic. The manual segment held a larger share of the market in 2019, whereas the electronic segment is anticipated to register a higher CAGR in the market during the forecast period.
Based on channel, the pipette market is segmented into single channel and multi-channel (8-channel, 12-channel, and others). The multi-channel segment held a larger share of the market in 2019 and is anticipated to register a higher CAGR in the market during the forecast period.
Based on volume, the pipette market is segmented into adjustable volume and fixed volume. The adjustable volume segment held a larger share of the market in 2019 and is anticipated to register a higher CAGR in the market during the forecast period.
Based on application, the pipette market is segmented into pharmaceutical laboratories, biotech laboratories, food and beverage, forensic laboratories, and others. The pharmaceutical laboratories segment held the largest share of the market in 2019 and is anticipated to register the highest CAGR in the market during the forecast period.
Some of the major primary and secondary sources for pipette market included in the report are European Excipient Certification Organization (EXCiPACT), Dubai Biotech Research Park, and others.